V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
Dodge & Cox Stock Fund Portfolio 13F
Dodge & Cox Stock Fund Holdings Activity
- Portfolio value:
- $100.98B≈ (+$9B≈)
- Previous value:
- $92.43B≈
- # of changes:
- 33
- New positions:
- 1
- Reported for:
- 31 Dec 2023 (Q4)
- Latest filing date:
- 27 Feb 2024
Dodge & Cox Stock Fund has disclosed a total of 33 changes to the portfolio in the (2023 Q4) SEC report(s): increased the number of shares of 11, bought 1 totally new, decreased the number of shares of 18 and completely sold out 3 position(s).
What stocks did Dodge & Cox Stock Fund buy in 2023 Q4?
During 2023 Q4 Dodge & Cox Stock Fund has bought 12 securities out of which top 5 purchases (by % change to portfolio) were (SCHW) Charles Schwab Corp (added shares +9.45%), (RTX) RTX Corp (added shares +26.16%), (CVS) CVS Health Corp (added shares +11.58%), (FIS) Fidelity National Information Services Inc (added shares +8.88%) and (NSC) Norfolk Southern Corp (added shares +28.61%).
33 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
International Flavors & Fragrances Inc
|
new
|
+5,332,703
|
5,332,703
|
+0.43%
|
$80.97
|
-1.86%($79.46)
|
0.43%
|
2023 Q4
|
≈ 0.25 years
|
|
|
|
Avantor Inc
|
+582.39%
|
+34,533,215
|
40,462,815
|
+0.78%
|
$22.83
|
-40.08%($13.68)
|
0.91%
|
2023 Q3
|
≈ 0.50 years
|
|
|
|
Neurocrine Biosciences Inc
|
+388.41%
|
+552,818
|
695,148
|
+0.07%
|
$131.76
|
+26.41%($166.56)
|
0.09%
|
2023 Q3
|
≈ 0.50 years
|
|
|
|
Baxter International Inc
|
+294.31%
|
+13,490,200
|
18,073,900
|
+0.52%
|
$38.66
|
-32.26%($26.19)
|
0.69%
|
2023 Q3
|
≈ 0.50 years
|
|
|
|
Zimmer Biomet Holdings Inc
|
+96.80%
|
+3,711,400
|
7,545,600
|
+0.45%
|
$121.70
|
-23.30%($93.34)
|
0.91%
|
2022 Q1
|
≈ 2.00 years
|
|
|
|
Dominion Energy Inc
|
+43.02%
|
+4,838,800
|
16,086,200
|
+0.23%
|
$47.00
|
+48.30%($69.70)
|
0.75%
|
2023 Q1
|
≈ 1.00 year
|
|
|
|
Norfolk Southern Corp
|
+28.61%
|
+1,157,400
|
5,202,300
|
+0.27%
|
$236.38
|
+41.81%($335.22)
|
1.22%
|
2023 Q2
|
≈ 0.75 years
|
|
|
|
RTX Corp
|
+26.16%
|
+5,992,300
|
28,898,100
|
+0.5%
|
$84.14
|
+155.63%($215.08)
|
2.41%
|
2019 Q3
|
≈ 4.50 years
|
|
|
|
CVS Health Corp
|
+11.58%
|
+2,123,900
|
20,465,000
|
+0.17%
|
$78.96
|
+33.31%($105.26)
|
1.60%
|
2019 Q3
|
≈ 4.50 years
|
|
|
|
Charles Schwab Corp
|
+9.45%
|
+4,999,135
|
57,921,035
|
+0.34%
|
$68.80
|
+52.91%($105.20)
|
3.95%
|
2019 Q3
|
≈ 4.50 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.